Translatum Medicus

Translatum Medicus is a biotechnology company that fixates on preclinical drug development to treat irreversible blindness.

Translatum Medicus is a business in biotechnology, medical, pharmaceutical based in Great Lakes, founded in 2016.

Within the biotechnology, medical, pharmaceutical space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in Great Lakes.

It is recorded at the Private company stage.

The company reports a headcount in the c_00011_00050 range.

Website: www.translatummedicus.com